{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:19:02Z","timestamp":1792685942130,"version":"4.5.0"},"reference-count":113,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1681\/asn.2014080834","type":"journal-article","created":{"date-parts":[[2015,2,5]],"date-time":"2015-02-05T00:38:44Z","timestamp":1423096724000},"page":"1248-1260","source":"Crossref","is-referenced-by-count":173,"title":["Assessment and Management of Hypertension in Transplant Patients"],"prefix":"10.1681","volume":"26","author":[{"given":"Matthew R.","family":"Weir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen D.","family":"Burgess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James E.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew Z.","family":"Fenves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Goldsmith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dianne","family":"McKay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Mehrotra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark M.","family":"Mitsnefes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenic A.","family":"Sica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra J.","family":"Taler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20230208","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/jama.2013.284427","article-title":"2014 evidence-based guideline for the management of high blood pressure in adults: Report from the panel members appointed to the Eighth Joint National Committee (JNC 8).","volume":"311","author":"James","year":"2014","journal-title":"JAMA"},{"key":"R2-7-20230208","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0041-1345(96)00066-8","article-title":"Hypertension in patients after renal transplantation.","volume":"29","author":"Budde","year":"1997","journal-title":"Transplant Proc"},{"key":"R3-7-20230208","doi-asserted-by":"crossref","first-page":"iii62","DOI":"10.1093\/ndt\/gfh1018","article-title":"Epidemiology of arterial hypertension in renal transplant patients: Changes over the last decade.","volume":"19","author":"Campistol","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"R4-7-20230208","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1053\/j.ajkd.2004.03.013","article-title":"Hypertension after kidney transplantation.","volume":"43","author":"Kasiske","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"R5-7-20230208","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0272-6386(93)70098-J","article-title":"Hypertension after renal transplantation.","volume":"21","author":"Ponticelli","year":"1993","journal-title":"Am J Kidney Dis"},{"key":"R6-7-20230208","first-page":"S107","article-title":"Does antihypertensive therapy modify chronic allograft failure?","volume":"52","author":"Raine","year":"1995","journal-title":"Kidney Int Suppl"},{"key":"R7-7-20230208","first-page":"S43","article-title":"Role of hypertension in chronic renal allograft dysfunction.","volume":"52","author":"Sanders","year":"1995","journal-title":"Kidney Int Suppl"},{"key":"R8-7-20230208","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0272-6386(93)70099-K","article-title":"The role of hypertension as a damaging factor for kidney grafts under cyclosporine therapy.","volume":"21","author":"Vianello","year":"1993","journal-title":"Am J Kidney Dis"},{"key":"R9-7-20230208","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1038\/ki.1995.162","article-title":"Racial differences in renal allograft survival: The role of systemic hypertension.","volume":"47","author":"Cosio","year":"1995","journal-title":"Kidney Int"},{"key":"R10-7-20230208","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0272-6386(97)90204-3","article-title":"Relationships between arterial hypertension and renal allograft survival in African-American patients.","volume":"29","author":"Cosio","year":"1997","journal-title":"Am J Kidney Dis"},{"key":"R11-7-20230208","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1681\/ASN.V22s37","article-title":"Pathophysiology and treatment of posttransplant hypertension.","volume":"2","author":"Luke","year":"1991","journal-title":"J Am Soc Nephrol"},{"key":"R12-7-20230208","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.trre.2010.02.001","article-title":"Hypertension in the kidney transplant recipient.","volume":"24","author":"Wadei","year":"2010","journal-title":"Transplant Rev (Orlando"},{"key":"R13-7-20230208","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1001\/jama.283.5.633","article-title":"Arterial hypertension and renal allograft survival.","volume":"283","author":"Mange","year":"2000","journal-title":"JAMA"},{"key":"R14-7-20230208","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/01.ASN.0000104574.04006.08","article-title":"Blood pressure and the survival of renal allografts from living donors.","volume":"15","author":"Mange","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"R15-7-20230208","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1046\/j.1523-1755.1998.00744.x","article-title":"Association of chronic kidney graft failure with recipient blood pressure. Collaborative Transplant Study.","volume":"53","author":"Opelz","year":"1998","journal-title":"Kidney Int"},{"key":"R16-7-20230208","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/j.1399-0012.2004.00235.x","article-title":"Cardiovascular disease in stable renal transplant patients in Norway: Morbidity and mortality during a 5-yr follow-up.","volume":"18","author":"Aakhus","year":"2004","journal-title":"Clin Transplant"},{"key":"R17-7-20230208","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1681\/ASN.V1341084","article-title":"Congestive heart failure in renal transplant recipients: Risk factors, outcomes, and relationship with ischemic heart disease.","volume":"13","author":"Rigatto","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"R18-7-20230208","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1053\/j.ajkd.2014.06.014","article-title":"Assessment of achieved clinic and ambulatory blood pressure recordings and outcomes during treatment in hypertensive patients with CKD: A multicenter prospective cohort study.","volume":"64","author":"Minutolo","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"R19-7-20230208","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1097\/01.TP.0000115345.16853.51","article-title":"Insights from ambulatory blood pressure monitoring: diagnosis of hypertension and diurnal blood pressure in renal transplant recipients.","volume":"77","author":"Haydar","year":"2004","journal-title":"Transplantation"},{"key":"R20-7-20230208","doi-asserted-by":"crossref","first-page":"3745","DOI":"10.1093\/ndt\/gfr143","article-title":"Home blood pressure (BP) monitoring in kidney transplant recipients is more adequate to monitor BP than office BP.","volume":"26","author":"Agena","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"R21-7-20230208","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1161\/HYPERTENSIONAHA.113.02148","article-title":"Ambulatory blood pressure measurement: What is the international consensus?","volume":"62","author":"O\u2019Brien","year":"2013","journal-title":"Hypertension"},{"key":"R22-7-20230208","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11906-011-0237-4","article-title":"Target organ damage in African American hypertension: Role of APOL1.","volume":"14","author":"Freedman","year":"2012","journal-title":"Curr Hypertens Rep"},{"key":"R23-7-20230208","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/FPC.0b013e328328d4e9","article-title":"Multidrug resistance-related protein 2 genotype of the donor affects kidney graft function.","volume":"19","author":"Grisk","year":"2009","journal-title":"Pharmacogenet Genomics"},{"key":"R24-7-20230208","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1681\/ASN.2004100882","article-title":"ABCB1 genotype of the donor but not of the recipient is a major risk factor for cyclosporine-related nephrotoxicity after renal transplantation.","volume":"16","author":"Hauser","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R25-7-20230208","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1093\/ndt\/gfm133","article-title":"Cytochrome P450 3A5 expression in the kidneys of patients with calcineurin inhibitor nephrotoxicity.","volume":"22","author":"Joy","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"R26-7-20230208","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1111\/j.1600-6143.2012.04033.x","article-title":"The APOL1 genotype of African American kidney transplant recipients does not impact 5-year allograft survival.","volume":"12","author":"Lee","year":"2012","journal-title":"Am J Transplant"},{"key":"R27-7-20230208","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1111\/j.1600-6143.2011.03513.x","article-title":"The APOL1 gene and allograft survival after kidney transplantation.","volume":"11","author":"Reeves-Daniel","year":"2011","journal-title":"Am J Transplant"},{"key":"R28-7-20230208","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/0272-6386(93)70097-I","article-title":"Nephron underdosing: A programmed cause of chronic renal allograft failure.","volume":"21","author":"Brenner","year":"1993","journal-title":"Am J Kidney Dis"},{"key":"R29-7-20230208","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1056\/NEJMra011078","article-title":"Subtle acquired renal injury as a mechanism of salt-sensitive hypertension.","volume":"346","author":"Johnson","year":"2002","journal-title":"N Engl J Med"},{"key":"R30-7-20230208","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1016\/j.transproceed.2012.09.086","article-title":"Cardiovascular risk in recipients with kidney transplants from expanded criteria donors.","volume":"44","author":"Blanca","year":"2012","journal-title":"Transplant Proc"},{"key":"R31-7-20230208","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1056\/NEJMoa035717","article-title":"Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection.","volume":"352","author":"Dragun","year":"2005","journal-title":"N Engl J Med"},{"key":"R32-7-20230208","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1136\/hrt.2009.192104","article-title":"Candesartan versus imidapril in hypertension: A randomised study to assess effects of anti-AT1 receptor autoantibodies.","volume":"97","author":"Wei","year":"2011","journal-title":"Heart"},{"key":"R33-7-20230208","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1586\/eci.11.56","article-title":"Receptor-activating autoantibodies and disease: Preeclampsia and beyond.","volume":"7","author":"Xia","year":"2011","journal-title":"Expert Rev Clin Immunol"},{"key":"R34-7-20230208","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/BF00852866","article-title":"Distinguishing the causes of post-transplantation hypertension.","volume":"5","author":"Curtis","year":"1991","journal-title":"Pediatr Nephrol"},{"key":"R35-7-20230208","doi-asserted-by":"crossref","first-page":"965","DOI":"10.4103\/1319-2442.118103","article-title":"A kink in transplantation: A rare cause of early graft dysfunction.","volume":"24","author":"Reddy","year":"2013","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"R36-7-20230208","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1007\/s11906-013-0381-0","article-title":"Hypertension after kidney transplantation: A pathophysiologic approach.","volume":"15","author":"Thomas","year":"2013","journal-title":"Curr Hypertens Rep"},{"key":"R37-7-20230208","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/TP.0b013e3181c518cc","article-title":"Steroid avoidance or withdrawal after renal transplantation increases the risk of acute rejection but decreases cardiovascular risk. A meta-analysis.","volume":"89","author":"Knight","year":"2010","journal-title":"Transplantation"},{"key":"R38-7-20230208","first-page":"123","article-title":"Prevalence of hypertension in a renal transplant population on alternate-day steroid therapy.","volume":"5","author":"Curtis","year":"1976","journal-title":"Clin Nephrol"},{"key":"R39-7-20230208","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1159\/000180750","article-title":"Effect of alternate-day steroids on renal transplant function. A controlled study.","volume":"17","author":"McDonald","year":"1976","journal-title":"Nephron"},{"key":"R40-7-20230208","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00345-007-0157-8","article-title":"Steroid- and calcineurin inhibitor free immunosuppression in kidney transplantation: State of the art and future developments.","volume":"25","author":"Giessing","year":"2007","journal-title":"World J Urol"},{"key":"R41-7-20230208","first-page":"250","article-title":"Antihypertensive and renal effects of enalapril in post-transplant hypertension.","volume":"27","author":"Hricik","year":"1987","journal-title":"Clin Nephrol"},{"key":"R42-7-20230208","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0022-5223(19)36181-1","article-title":"Long-term hemodynamic results after cardiac transplantation.","volume":"94","author":"Frist","year":"1987","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R43-7-20230208","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/ndt\/gft447","article-title":"Calcineurin inhibitors in HLA-identical living related donor kidney transplantation.","volume":"29","author":"Verghese","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"R44-7-20230208","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/sj.bjp.0705659","article-title":"Regional haemodynamic effects of cyclosporine A, tacrolimus and sirolimus in conscious rats.","volume":"141","author":"Gardiner","year":"2004","journal-title":"Br J Pharmacol"},{"key":"R45-7-20230208","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1172\/JCI117222","article-title":"Vascular mechanisms of cyclosporin-induced hypertension in the rat.","volume":"93","author":"Roullet","year":"1994","journal-title":"J Clin Invest"},{"key":"R46-7-20230208","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1038\/nm.2497","article-title":"The calcineurin inhibitor tacrolimus activates the renal sodium chloride cotransporter to cause hypertension.","volume":"17","author":"Hoorn","year":"2011","journal-title":"Nat Med"},{"key":"R47-7-20230208","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1093\/ndt\/gfn004","article-title":"Efficacy and safety of tacrolimus compared with ciclosporin A in renal transplantation: Three-year observational results.","volume":"23","author":"Kr\u00e4mer","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"R48-7-20230208","doi-asserted-by":"crossref","first-page":"S296","DOI":"10.1681\/ASN.2006080930","article-title":"Impact of tacrolimus and mycophenolate mofetil combination on cardiovascular risk profile after kidney transplantation.","volume":"17","author":"Morales","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"R49-7-20230208","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1111\/j.1523-1755.2004.00912.x","article-title":"Aortic pulse wave velocity in renal transplant patients.","volume":"66","author":"Bahous","year":"2004","journal-title":"Kidney Int"},{"key":"R50-7-20230208","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1097\/01.ASN.0000037677.16961.DF","article-title":"Increased arterial stiffness in young adults with end-stage renal disease since childhood.","volume":"13","author":"Groothoff","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"R51-7-20230208","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ajhg.2010.11.014","article-title":"Identification of a systemic lupus erythematosus susceptibility locus at 11p13 between PDHX and CD44 in a multiethnic study.","volume":"88","author":"Lessard","year":"2011","journal-title":"Am J Hum Genet"},{"key":"R52-7-20230208","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1007\/s00125-010-1996-1","article-title":"Genetic associations in diabetic nephropathy: A meta-analysis.","volume":"54","author":"Mooyaart","year":"2011","journal-title":"Diabetologia"},{"key":"R53-7-20230208","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1053\/j.ajkd.2009.06.034","article-title":"Association of kidney function with coronary atherosclerosis and calcification in autopsy samples from Japanese elders: The Hisayama study.","volume":"55","author":"Nakano","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"R54-7-20230208","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1097\/01.RVI.0000141338.62574.F4","article-title":"Transplant renal artery stenosis: Outcome after percutaneous intervention.","volume":"15","author":"Beecroft","year":"2004","journal-title":"J Vasc Interv Radiol"},{"key":"R55-7-20230208","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/01.TP.0000072805.40996.B1","article-title":"Iliac artery stenosis proximal to a kidney transplant: Clinical findings, duplex-sonographic criteria, treatment, and outcome.","volume":"76","author":"Voiculescu","year":"2003","journal-title":"Transplantation"},{"key":"R56-7-20230208","first-page":"261","article-title":"Hypokalemia secondary to primary hyperaldosteronism in a renal transplant recipient.","volume":"24","author":"Cook","year":"1985","journal-title":"Clin Nephrol"},{"key":"R57-7-20230208","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0272-6386(98)70056-3","article-title":"Primary hyperaldosteronism causing posttransplantation hypertension: Localization by adrenal vein sampling.","volume":"31","author":"Fahmy","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"R58-7-20230208","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1016\/j.transproceed.2004.10.004","article-title":"Renal transplantation unveils Conn\u2019s syndrome: A case report.","volume":"36","author":"Harzallah","year":"2004","journal-title":"Transplant Proc"},{"key":"R59-7-20230208","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1097\/00007890-200004150-00050","article-title":"Unmasking of primary hyperaldosteronism by renal transplantation.","volume":"69","author":"Kaplan","year":"2000","journal-title":"Transplantation"},{"key":"R60-7-20230208","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1093\/ndt\/17.6.1129","article-title":"Hypokalaemia and hypertension early after kidney transplantation.","volume":"17","author":"Tintillier","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"R61-7-20230208","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1159\/000168719","article-title":"Primary aldosteronism detected after renal transplantation.","volume":"14","author":"Yang","year":"1994","journal-title":"Am J Nephrol"},{"key":"R62-7-20230208","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nrneph.2010.158","article-title":"A case of primary aldosteronism revealed after renal transplantation.","volume":"7","author":"Hoorn","year":"2011","journal-title":"Nat Rev Nephrol"},{"key":"R64-7-20230208","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1053\/j.ajkd.2013.03.018","article-title":"KDOQI US commentary on the 2012 KDIGO clinical practice guideline for management of blood pressure in CKD.","volume":"62","author":"Taler","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"R65-7-20230208","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.transproceed.2006.02.103","article-title":"The impact of daily sodium intake on posttransplant hypertension in kidney allograft recipients.","volume":"38","author":"Keven","year":"2006","journal-title":"Transplant Proc"},{"key":"R66-7-20230208","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0002-9343(88)80331-0","article-title":"Hypertension in cyclosporine-treated renal transplant recipients is sodium dependent.","volume":"85","author":"Curtis","year":"1988","journal-title":"Am J Med"},{"key":"R67-7-20230208","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1001\/archinte.1995.00430100075009","article-title":"The effects of nonsteroidal anti-inflammatory drugs on blood pressures of patients with hypertension controlled by verapamil.","volume":"155","author":"Houston","year":"1995","journal-title":"Arch Intern Med"},{"key":"R68-7-20230208","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1161\/01.HYP.31.5.1088","article-title":"Influence of race and dietary salt on the antihypertensive efficacy of an angiotensin-converting enzyme inhibitor or a calcium channel antagonist in salt-sensitive hypertensives.","volume":"31","author":"Weir","year":"1998","journal-title":"Hypertension"},{"key":"R69-7-20230208","first-page":"1469","article-title":"Calcium blockers inhibit cyclosporine A-induced hyperreactivity of vascular smooth muscle cells.","volume":"5","author":"Grze\u015bk","year":"2012","journal-title":"Mol Med Rep"},{"key":"R70-7-20230208","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0140-6736(02)08089-3","article-title":"Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): A randomised trial against atenolol.","volume":"359","author":"Dahl\u00f6f","year":"2002","journal-title":"Lancet"},{"key":"R71-7-20230208","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S0140-6736(03)14286-9","article-title":"Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: Randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study).","volume":"362","author":"Fox","year":"2003","journal-title":"Lancet"},{"key":"R72-7-20230208","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/S0140-6736(02)08090-X","article-title":"Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): A randomised trial against atenolol.","volume":"359","author":"Lindholm","year":"2002","journal-title":"Lancet"},{"key":"R73-7-20230208","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","article-title":"Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.","volume":"342","author":"Yusuf","year":"2000","journal-title":"N Engl J Med"},{"key":"R75-7-20230208","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1001\/jama.285.21.2719","article-title":"Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: A randomized controlled trial.","volume":"285","author":"Agodoa","year":"2001","journal-title":"JAMA"},{"key":"R76-7-20230208","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy.","volume":"345","author":"Brenner","year":"2001","journal-title":"N Engl J Med"},{"key":"R77-7-20230208","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1056\/NEJMoa011303","article-title":"Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes.","volume":"345","author":"Lewis","year":"2001","journal-title":"N Engl J Med"},{"key":"R78-7-20230208","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000357205","article-title":"Specific management of anemia and hypertension in renal transplant recipients: Influence of renin-angiotensin system blockade.","volume":"39","author":"Salzberg","year":"2014","journal-title":"Am J Nephrol"},{"key":"R79-7-20230208","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1016\/j.transproceed.2006.08.066","article-title":"Efficacy and safety of valsartan, an angiotensin II receptor antagonist, in hypertension after renal transplantation: A randomized multicenter study.","volume":"38","author":"Andr\u00e9s","year":"2006","journal-title":"Transplant Proc"},{"key":"R80-7-20230208","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1093\/ndt\/gfk058","article-title":"A randomized trial comparing losartan with amlodipine as initial therapy for hypertension in the early post-transplant period.","volume":"21","author":"Formica","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"R81-7-20230208","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1681\/ASN.2012080777","article-title":"Angiotensin II blockade in kidney transplant recipients.","volume":"24","author":"Ibrahim","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"R82-7-20230208","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1681\/ASN.V124822","article-title":"Effects of losartan and amlodipine on intrarenal hemodynamics and TGF-beta(1) plasma levels in a crossover trial in renal transplant recipients.","volume":"12","author":"I\u00f1igo","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"R83-7-20230208","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0041-1345(01)02818-4","article-title":"Double-blind, crossover, comparative study of doxazosin and enalapril in the treatment of hypertension in renal transplant patients under cyclosporine immunosuppression.","volume":"34","author":"Mart\u00ednez-Castelao","year":"2002","journal-title":"Transplant Proc"},{"key":"R84-7-20230208","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1097\/00007890-200112150-00013","article-title":"Sustained improvement of renal graft function for two years in hypertensive renal transplant recipients treated with nifedipine as compared to lisinopril.","volume":"72","author":"Midtvedt","year":"2001","journal-title":"Transplantation"},{"key":"R85-7-20230208","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1093\/ndt\/gfp581","article-title":"Candesartan improves blood pressure control and reduces proteinuria in renal transplant recipients: Results from SECRET.","volume":"25","author":"Philipp","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"R86-7-20230208","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1432-2277.2003.tb00306.x","article-title":"Long-term follow-up of ACE-inhibitor versus beta-blocker treatment and their effects on blood pressure and kidney function in renal transplant recipients.","volume":"16","author":"Suwelack","year":"2003","journal-title":"Transpl Int"},{"key":"R87-7-20230208","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1111\/j.1600-6143.2007.01928.x","article-title":"Renin angiotensin system blockade in kidney transplantation: A systematic review of the evidence.","volume":"7","author":"Hiremath","year":"2007","journal-title":"Am J Transplant"},{"key":"R89-7-20230208","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1681\/ASN.2005090955","article-title":"Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation.","volume":"17","author":"Heinze","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"R90-7-20230208","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1681\/ASN.2006050543","article-title":"No improvement of patient or graft survival in transplant recipients treated with angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers: A collaborative transplant study report.","volume":"17","author":"Opelz","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"R91-7-20230208","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/ndt\/gfm574","article-title":"The Canadian ACE-inhibitor trial to improve renal outcomes and patient survival in kidney transplantation--study design.","volume":"23","author":"Knoll","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"R92-7-20230208","first-page":"236","article-title":"Post-transplant hypertension in the absence of rejection or recurrent disease.","volume":"15","author":"Ingelfinger","year":"1981","journal-title":"Clin Nephrol"},{"key":"R94-7-20230208","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1399-3046.2009.01141.x","article-title":"High prevalence of the metabolic syndrome and associated left ventricular hypertrophy in pediatric renal transplant recipients.","volume":"14","author":"Wilson","year":"2010","journal-title":"Pediatr Transplant"},{"key":"R95-7-20230208","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1038\/ki.2011.232","article-title":"Demographics of blood pressure and hypertension in children on renal replacement therapy in Europe.","volume":"80","author":"Kramer","year":"2011","journal-title":"Kidney Int"},{"key":"R96-7-20230208","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.1093\/ndt\/gfr804","article-title":"Systemic arterial hypertension in children following renal transplantation: Prevalence and risk factors.","volume":"27","author":"Sinha","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"R97-7-20230208","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1093\/ndt\/gfr784","article-title":"Progression to hypertension in non-hypertensive children following renal transplantation.","volume":"27","author":"Sinha","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"R98-7-20230208","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0895-7061(97)00484-6","article-title":"Hypertension in young patients after renal transplantation: Ambulatory blood pressure monitoring versus casual blood pressure.","volume":"11","author":"Calzolari","year":"1998","journal-title":"Am J Hypertens"},{"key":"R99-7-20230208","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/S0022-3476(00)90016-7","article-title":"Ambulatory blood pressure monitoring in children with aortic coarctation and kidney transplantation.","volume":"136","author":"Giordano","year":"2000","journal-title":"J Pediatr"},{"key":"R100-7-20230208","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1046\/j.1523-1755.1999.00667.x","article-title":"Left ventricular hypertrophy, treadmill tests, and 24-hour blood pressure in pediatric transplant patients.","volume":"56","author":"Matteucci","year":"1999","journal-title":"Kidney Int"},{"key":"R101-7-20230208","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.transproceed.2004.04.081","article-title":"Ambulatory blood pressure monitoring in children after renal transplantation.","volume":"36","author":"Seeman","year":"2004","journal-title":"Transplant Proc"},{"key":"R102-7-20230208","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1399-3046.2006.00521.x","article-title":"Predominance of nocturnal hypertension in pediatric renal allograft recipients.","volume":"10","author":"McGlothan","year":"2006","journal-title":"Pediatr Transplant"},{"key":"R103-7-20230208","first-page":"1059","article-title":"Lack of adequate blood pressure control in the morning and evening periods in medicated hypertensive patients considered to be controlled in the office.","volume":"24","author":"Pol\u00f3nia","year":"2005","journal-title":"Rev Port Cardiol"},{"key":"R104-7-20230208","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1034\/j.1399-3046.2001.t01-1-00051.x","article-title":"Short-term pediatric renal transplant survival: Blood pressure and allograft function.","volume":"5","author":"Mitsnefes","year":"2001","journal-title":"Pediatr Transplant"},{"key":"R105-7-20230208","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1681\/ASN.V1061324","article-title":"Antihypertensive medication and renal allograft failure: A North American Pediatric Renal Transplant Cooperative Study report.","volume":"10","author":"Sorof","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"R106-7-20230208","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0022-3476(03)00209-9","article-title":"Early posttransplantation hypertension and poor long-term renal allograft survival in pediatric patients.","volume":"143","author":"Mitsnefes","year":"2003","journal-title":"J Pediatr"},{"key":"R107-7-20230208","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1111\/j.1600-6143.2011.03691.x","article-title":"Change in mortality risk over time in young kidney transplant recipients.","volume":"11","author":"Foster","year":"2011","journal-title":"Am J Transplant"},{"key":"R108-7-20230208","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/j.1399-3046.2006.00565.x","article-title":"Left ventricular hypertrophy in pediatric kidney transplant recipients: Long-term follow-up study.","volume":"10","author":"Bullington","year":"2006","journal-title":"Pediatr Transplant"},{"key":"R109-7-20230208","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1007\/s00467-004-1672-0","article-title":"Changes of blood pressure and left ventricular mass in pediatric renal transplantation.","volume":"19","author":"Kitzmueller","year":"2004","journal-title":"Pediatr Nephrol"},{"key":"R110-7-20230208","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1034\/j.1399-3046.2001.005004279.x","article-title":"Changes in left ventricular mass index in children and adolescents after renal transplantation.","volume":"5","author":"Mitsnefes","year":"2001","journal-title":"Pediatr Transplant"},{"key":"R111-7-20230208","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/j.1399-3046.2011.01547.x","article-title":"Use of annual ABPM, and repeated carotid scan and echocardiography to monitor cardiovascular health over nine yr in pediatric and young adult renal transplant recipients.","volume":"15","author":"Balzano","year":"2011","journal-title":"Pediatr Transplant"},{"key":"R112-7-20230208","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1007\/s00467-008-0855-5","article-title":"Improved left ventricular mass index in children after renal transplantation.","volume":"23","author":"Becker-Cohen","year":"2008","journal-title":"Pediatr Nephrol"},{"key":"R113-7-20230208","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1399-3046.2007.00837.x","article-title":"Prospective analysis of carotid arterial wall structure in pediatric renal transplants with ambulatory normotension and in treated hypertensive recipients.","volume":"12","author":"Krmar","year":"2008","journal-title":"Pediatr Transplant"},{"key":"R114-7-20230208","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1093\/ndt\/gfn083","article-title":"Evolution of large-vessel arteriopathy in paediatric patients with chronic kidney disease.","volume":"23","author":"Litwin","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"R115-7-20230208","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1161\/01.CIR.0000133412.53089.26","article-title":"Abnormal carotid artery structure and function in children and adolescents with successful renal transplantation.","volume":"110","author":"Mitsnefes","year":"2004","journal-title":"Circulation"},{"key":"R116-7-20230208","first-page":"502","article-title":"2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)","volume":"31","author":"James","year":"2014","journal-title":"JAMA"},{"key":"R117-7-20230208","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1097\/01.hjh.0000431740.32696.cc","article-title":"2013 ESH\/ESC Guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).","volume":"31","author":"Mancia","year":"2013","journal-title":"J Hypertens"}],"container-title":["Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00001751-201506000-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T19:26:00Z","timestamp":1786130760000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001751-201506000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":113,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1681\/asn.2014080834","relation":{},"ISSN":["1046-6673"],"issn-type":[{"value":"1046-6673","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]}}}